Main > NEUROLOGY. > Multiple Sclerosis > Treatment > AlemtuzuMAb (Anti CD52 MAb)



AlemtuzuMAb (Anti CD52 MAb)'s subsections
Co.: USA. G. (Phase III/Patent)

AlemtuzuMAb (Anti CD52 MAb)'s products
This section has no products